X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
adult (6) 6
middle aged (6) 6
female (5) 5
male (5) 5
adolescent (4) 4
immunology (4) 4
medical research (4) 4
mice (4) 4
research article (4) 4
surveys (4) 4
adenocarcinoma (3) 3
aged (3) 3
aged, 80 and over (3) 3
animals (3) 3
autoantibodies (3) 3
barrett's esophagus (3) 3
california (3) 3
cancer (3) 3
child (3) 3
cross-sectional studies (3) 3
gene expression (3) 3
marketing (3) 3
oncology (3) 3
original (3) 3
patients (3) 3
physiological aspects (3) 3
public, environmental & occupational health (3) 3
research (3) 3
smoking prevention (3) 3
t cells (3) 3
usa (3) 3
young adult (3) 3
abridged index medicus (2) 2
adenocarcinoma - diagnosis (2) 2
advertising (2) 2
advertising as topic (2) 2
advertising as topic - legislation & jurisprudence (2) 2
age (2) 2
allergy and immunology (2) 2
analysis (2) 2
antibodies (2) 2
antiphospholipid syndrome (2) 2
antiphospholipid syndrome - immunology (2) 2
arbitration (2) 2
autoantibodies - blood (2) 2
barrett esophagus - diagnosis (2) 2
barrett’s esophagus (2) 2
beta 2-glycoprotein i (2) 2
binding (2) 2
chemistry (2) 2
children (2) 2
cigarettes (2) 2
clinical trials (2) 2
commerce (2) 2
consent (2) 2
cytokines (2) 2
dendritic cells (2) 2
deoxycholic acid (2) 2
disputes (2) 2
epithelium (2) 2
esophageal adenocarcinoma (2) 2
esophageal neoplasms - diagnosis (2) 2
esophagus (2) 2
extracellular matrix (2) 2
genetic aspects (2) 2
genetics (2) 2
glycoproteins - immunology (2) 2
hematology (2) 2
highway construction (2) 2
immunohistochemistry (2) 2
immunology and allergy (2) 2
infant (2) 2
international cooperation (2) 2
international courts (2) 2
international disputes (2) 2
interventions (2) 2
lupus anticoagulant (2) 2
medicine (2) 2
medicine, experimental (2) 2
medicine, research & experimental (2) 2
multidisciplinary sciences (2) 2
oil exploration (2) 2
original article (2) 2
original articles (2) 2
population (2) 2
proteins (2) 2
public health (2) 2
quality (2) 2
regression analysis (2) 2
rural areas (2) 2
science (2) 2
smoking (2) 2
studies (2) 2
tissue transglutaminase (2) 2
tobacco (2) 2
tobacco industry (2) 2
tobacco industry - legislation & jurisprudence (2) 2
treaties (2) 2
tribunals (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


SAE technical paper series, Volume 2001-01-2225.
The Waste and Hygiene Compartment will serve as the primary facility for metabolic waste management and personal hygiene on the United States segment of the... 
Environment | Logistics
eJournal
Journal Article
PloS one, ISSN 1932-6203, 2011, Volume 6, Issue 12, p. e28648
...About the Authors: Vincent O'Reilly Affiliation: Department of Immunology and Institute of Molecular Medicine, Trinity College Dublin, St. James's Hospital... 
B-CELLS | V(ALPHA)14 NKT CELLS | LUNG-CANCER | CANCER-PATIENTS | MULTIDISCIPLINARY SCIENCES | RECEPTOR EXPRESSION | MATURE DENDRITIC CELLS | LIGAND ALPHA-GALACTOSYLCERAMIDE | PHASE-I | T(H)2 BIAS | CUTTING EDGE | T-Lymphocyte Subsets - immunology | CD8-Positive T-Lymphocytes - cytology | Natural Killer T-Cells - drug effects | Mitogens - pharmacology | T-Lymphocyte Subsets - cytology | Humans | CD4-Positive T-Lymphocytes - immunology | T-Lymphocyte Subsets - drug effects | Cell Membrane - metabolism | Cytotoxicity, Immunologic - drug effects | Cell Membrane - drug effects | Natural Killer T-Cells - secretion | CD4-Positive T-Lymphocytes - cytology | Cytokines - secretion | Natural Killer T-Cells - cytology | Phenotype | Animals | Neoplasms - immunology | CD8-Positive T-Lymphocytes - drug effects | Cell Proliferation - drug effects | Mice | HeLa Cells | CD8-Positive T-Lymphocytes - immunology | CD4-Positive T-Lymphocytes - drug effects | Natural Killer T-Cells - immunology | Leukemia | Clinical trials | Interleukin 22 | Cytotoxicity | Stimulation | Lymphocytes T | CD40L protein | Invariants | Interleukin 4 | Immunology | Interleukin 5 | Lymphocytes | Tumor necrosis factor-TNF | Natural killer cells | CD56 antigen | Interleukin 9 | Medical research | Antigens | Immunoglobulins | Cytokines | Dendritic cells | Immunoregulation | Medical treatment | Interleukin 12 | Interleukin 13 | T cell receptors | Tumor cell lines | Tumor necrosis factor-α | Chemical compounds | Interleukin 17 | CD4 antigen | Asthma | Medicine | CD1d antigen | Hospitals | γ-Interferon | Interleukin 10 | Interferon | Diabetes | Pharmaceuticals
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2017, Volume 139, Issue 2, pp. 597 - 606.e4
Background Activated phosphoinositide 3-kinase δ syndrome (APDS) is a recently described combined immunodeficiency resulting from gain-of-function mutations in... 
Allergy and Immunology | Recurrence | Humans | Middle Aged | Child, Preschool | Infant | Male | Antibiotic Prophylaxis | Class I Phosphatidylinositol 3-Kinases/antagonists & inhibitors | Young Adult | Immunoglobulins, Intravenous/therapeutic use | Enzyme Inhibitors/therapeutic use | Lymphoproliferative Disorders/genetics | Adult | Female | Surveys and Questionnaires | Child | Respiratory Tract Infections/genetics | Mutation/genetics | Hematopoietic Stem Cell Transplantation | International Cooperation | Herpesviridae Infections/genetics | Animals | Adolescent | Survival Analysis | Mice | Immunologic Deficiency Syndromes/genetics | Cohort Studies | Activated phosphoinositide 3-kinase δ syndrome | hematopoietic stem cell transplantation | phosphoinositide 3-kinase δ | immunodeficiency | phosphoinositide 3-kinase inhibitor | PIK3CD gene | bronchiectasis | p110δ-activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency | Activated phosphoinositide 3-kinase delta syndrome | IMMUNOLOGICAL FEATURES | HYPER-IGM SYNDROME | p110 delta-activating mutation causing senescent T cells | hematopoietic stem cell | COMMON VARIABLE IMMUNODEFICIENCY | PIK3CD | IMMUNOLOGY | lymphadenopathy | REFERENCE VALUES | P110-DELTA | phosphoinositide 3-kinase delta | P110 DELTA | B-CELL | ALLERGY | transplantation | MUTATIONS | Class I Phosphatidylinositol 3-Kinases - genetics | Herpesviridae Infections - mortality | Respiratory Tract Infections - genetics | Lymphoproliferative Disorders - therapy | Respiratory Tract Infections - mortality | Respiratory Tract Infections - therapy | Immunologic Deficiency Syndromes - mortality | Herpesviridae Infections - genetics | Immunologic Deficiency Syndromes - therapy | Lymphoproliferative Disorders - genetics | Mutation - genetics | Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Enzyme Inhibitors - therapeutic use | Lymphoproliferative Disorders - mortality | Herpesviridae Infections - therapy | Immunoglobulins, Intravenous - therapeutic use | Immunologic Deficiency Syndromes - genetics | Immune Deficiencies, Infection, and Systemic Immune Disorders | HSCT, Hematopoietic stem cell transplantation | BALF, Bronchoalveolar lavage fluid | CT, Computed tomography | APDS, Activated phosphoinositide-3 kinase δ syndrome | GOF, Gain of function | PI3K, Phosphoinositide 3-kinase | HSV, Herpes simplex virus | CMV, Cytomegalovirus | OR, Odds ratio | PPV, Pneumococcal polysaccharide vaccine | CNS, Central nervous system
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 07/2017, Volume 66, Issue 7, pp. 841 - 850
... is an independent prognostic indicator in esophageal adenocarcinoma patients Margaret R. Dunne1 · Adriana J. Michielsen1 · Katie E. O’Sullivan1 · Mary Clare Cathcart1 · Ronan... 
Prognostic markers | Inflammation-associated cancer | Barrett’s esophagus | HLA-DR | Survival | Esophageal adenocarcinoma | IFN-GAMMA | IMMUNOLOGY | CHEMOTHERAPY | CLASS-II ANTIGEN | COLORECTAL-CANCER PATIENTS | ONCOLOGY | Barrett's esophagus | NEOADJUVANT CHEMORADIOTHERAPY | INFILTRATING IMMUNE CELLS | CARCINOMA | LYMPHOCYTE INFILTRATION | IN-SITU | Immunohistochemistry | Adenocarcinoma - pathology | Prognosis | Epithelial Cells - chemistry | Stromal Cells - pathology | Tissue Array Analysis | Humans | Middle Aged | Male | Esophagitis - pathology | Esophageal Neoplasms - pathology | Barrett Esophagus - pathology | Precancerous Conditions - diagnosis | Aged, 80 and over | Esophageal Neoplasms - mortality | Esophagitis - diagnosis | Adult | Esophageal Neoplasms - diagnosis | Female | Precancerous Conditions - pathology | Adenocarcinoma - chemistry | Esophageal Neoplasms - chemistry | Biomarkers, Tumor - analysis | Stromal Cells - chemistry | Kaplan-Meier Estimate | Epithelial Cells - pathology | Esophagus - chemistry | Disease Progression | Adenocarcinoma - diagnosis | Esophagus - pathology | HLA-DR Antigens - analysis | Barrett Esophagus - diagnosis | Aged | Adenocarcinoma - mortality | Adenocarcinoma | Medical research | Medical colleges | Dysplasia | Analysis | Gastrointestinal diseases | Medicine, Experimental | Development and progression | Epithelium | Esophageal cancer | Tumors | Stroma | Esophagitis | Multivariate analysis | Patients | Esophagus | Incidence | Immunology | Quality | Medical prognosis | Histocompatibility antigen HLA | Health risk assessment | Cancer | Original
Journal Article
Global mental health, ISSN 2054-4251, 2016, Volume 3, p. e23
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 2019, Volume 20, Issue 18, p. 4449
Journal Article
Life support & biosphere science, ISSN 1069-9422, 01/2000, Volume 7, Issue 1, pp. 128 - 128
The incinerating toilet contains a chamber that completely incinerates feces, urine, and waste paper by exposure to intense electric heat. Oxidation and... 
Journal Article
CANCERS, ISSN 2072-6694, 07/2020, Volume 12, Issue 7, p. 1921
Cancer clinical trials (CCTs) are critical to translation and development of better therapies to improve outcomes. CCTs require adequate patient involvement... 
POPULATION | EQ-5D | OLDER | BARRIERS | ENROLLMENT | patient perception | ONCOLOGY | CONSENT | understanding | cancer | clinical trials | PARTICIPATION | AGE | Participation | Medical research | Subpopulations | Activities of daily living | Demography | Decision making | Clinical trials | Oncology | Medical diagnosis | Patients | Problems | Pain | Anxieties | Socioeconomic factors | Questionnaires | Age | Cancer
Journal Article
Journal Article